221 related articles for article (PubMed ID: 25578726)
1. Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation.
Schmidt JM; Panzilius E; Bartsch HS; Irmler M; Beckers J; Kari V; Linnemann JR; Dragoi D; Hirschi B; Kloos UJ; Sass S; Theis F; Kahlert S; Johnsen SA; Sotlar K; Scheel CH
Cell Rep; 2015 Jan; 10(2):131-9. PubMed ID: 25578726
[TBL] [Abstract][Full Text] [Related]
2. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
[TBL] [Abstract][Full Text] [Related]
3. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation.
Ma G; He J; Yu Y; Xu Y; Yu X; Martinez J; Lonard DM; Xu J
Int J Biol Sci; 2015; 11(5):618-28. PubMed ID: 25892968
[TBL] [Abstract][Full Text] [Related]
5. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
6. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.
Li QQ; Xu JD; Wang WJ; Cao XX; Chen Q; Tang F; Chen ZQ; Liu XP; Xu ZD
Clin Cancer Res; 2009 Apr; 15(8):2657-65. PubMed ID: 19336515
[TBL] [Abstract][Full Text] [Related]
7. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
8. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
9. The ethanolic extract of bark from Salix aegyptiaca L. inhibits the metastatic potential and epithelial to mesenchymal transition of colon cancer cell lines.
Enayat S; Banerjee S
Nutr Cancer; 2014; 66(6):999-1008. PubMed ID: 25175673
[TBL] [Abstract][Full Text] [Related]
10. Twist1-Induced Epithelial Dissemination Requires Prkd1 Signaling.
Georgess D; Padmanaban V; Sirka OK; Coutinho K; Choi A; Frid G; Neumann NM; Inoue T; Ewald AJ
Cancer Res; 2020 Jan; 80(2):204-218. PubMed ID: 31676574
[TBL] [Abstract][Full Text] [Related]
11. Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells.
Yoon NA; Jo HG; Lee UH; Park JH; Yoon JE; Ryu J; Kang SS; Min YJ; Ju SA; Seo EH; Huh IY; Lee BJ; Park JW; Cho WJ
Oncotarget; 2016 Feb; 7(8):8931-43. PubMed ID: 26840564
[TBL] [Abstract][Full Text] [Related]
12. Twist1 induces distinct cell states depending on TGFBR1-activation.
Dragoi D; Krattenmacher A; Mishra VK; Schmidt JM; Kloos UJ; Meixner LK; Hauck SM; Buggenthin F; Schwartz D; Marr C; Johnsen SA; Scheel CH
Oncotarget; 2016 May; 7(21):30396-407. PubMed ID: 27105506
[TBL] [Abstract][Full Text] [Related]
13. TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.
Stankic M; Pavlovic S; Chin Y; Brogi E; Padua D; Norton L; Massagué J; Benezra R
Cell Rep; 2013 Dec; 5(5):1228-42. PubMed ID: 24332369
[TBL] [Abstract][Full Text] [Related]
14. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
15. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression.
Nairismägi ML; Vislovukh A; Meng Q; Kratassiouk G; Beldiman C; Petretich M; Groisman R; Füchtbauer EM; Harel-Bellan A; Groisman I
Oncogene; 2012 Nov; 31(47):4960-6. PubMed ID: 22266852
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.
Tsai JH; Donaher JL; Murphy DA; Chau S; Yang J
Cancer Cell; 2012 Dec; 22(6):725-36. PubMed ID: 23201165
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.
Latifi A; Abubaker K; Castrechini N; Ward AC; Liongue C; Dobill F; Kumar J; Thompson EW; Quinn MA; Findlay JK; Ahmed N
J Cell Biochem; 2011 Oct; 112(10):2850-64. PubMed ID: 21618587
[TBL] [Abstract][Full Text] [Related]
18. Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression.
Foubert E; De Craene B; Berx G
Breast Cancer Res; 2010; 12(3):206. PubMed ID: 20594364
[TBL] [Abstract][Full Text] [Related]
19. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
Nam EH; Lee Y; Moon B; Lee JW; Kim S
Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the role of FOXQ1 in colorectal cancer metastasis.
Abba M; Patil N; Rasheed K; Nelson LD; Mudduluru G; Leupold JH; Allgayer H
Mol Cancer Res; 2013 Sep; 11(9):1017-28. PubMed ID: 23723077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
